Table 6 |
||||||||
| Genotype and allele frequencies from previous case–control studies of Japanese populations investigating the association betweenUCHL1 S18Y polymorphism and Parkinson’s disease* | ||||||||
| Zhang et al. [[6]] | Momose et al. [[7]] | Mizuta et al. [[9]]† | Snapinn et al. [[25]] | |||||
| Cases | Controls | Cases | Controls | Cases | Controls | Cases | Controls | |
| Genotype | N = 160 | N = 160 | N = 230 | N = 248 | N = 613 | N = 736 | N = 605 | N = 1620 |
| CC | 52 (32.5) | 35 (21.9) | 71 (30.9) | 61 (24.6) | 149 (24.3) | 199 (27.0) | 150 (24.8) | 412 (25.4) |
| CA | 77 (48.1) | 86 (53.8) | 119 (51.7) | 122 (49.2) | 340 (55.5) | 366 (49.7) | 313 (51.7) | 805 (49.7) |
| AA | 31 (19.4) | 39 (24.4) | 40 (17.4) | 65 (26.2) | 124 (20.2) | 171 (23.2) | 142 (23.5) | 403 (24.9) |
| Allele | N = 320 | N = 320 | N = 460 | N = 496 | N = 1226 | N = 1472 | N = 1210 | N = 3240 |
| C | 181 (56.6) | 156 (48.8) | 261 (56.7) | 244 (49.2) | 638 (52.0) | 764 (51.9) | 613 (50.7) | 1629 (50.3) |
| A | 139 (43.4) | 164 (51.3) | 199 (43.3) | 252 (50.8) | 588 (48.0) | 708 (48.1) | 597 (49.3) | 1611 (49.7) |
* n (%).
†Data were based on a meta-analysis by Ragland et al. [5]; excluded cases included in genotype counts in the Momose et al. study [7].
Miyake et al. BMC Neurology 2012 12:62 doi:10.1186/1471-2377-12-62
